EGFR and neoplasm: Several studies have demonstrated that the EGFR mutations detected in plasma ctDNA are highly concordant with those detected in the tumor tissue of patients [11, 12, 13], indicating that ctDNA in plasma can serve as an alternative to tissue biopsy.